跳至主要内容
临床试验/ITMCTR2000002962
ITMCTR2000002962尚未招募1 期

Traditional Chinese Medicine for Pulmonary Fibrosis, Pulmonary Function and Quality of Life in Patients With Novel Coronavirus Pneumonia (COVID-19) in Convalescent Period: a Randomized Controlled Trial

1. Xinhua affiliated hospital, Hubei University of Chinese Medicine; 2. Hubei Provincial Hospital of Integrated Chinese and Western Medicine0 个研究点开始时间: 待定最近更新:
适应症

试验速览

阶段
1 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional study

入排标准

年龄范围
18 至 70(—)
性别
All

入选标准

  • 1. patients diagnosed as Pneumonia caused by new coronavirus infection (2019-nCoV);
  • 2. virus turned negative after treatment;
  • 3. Patients diagnosed with pulmonary fibrosis;
  • 4. aged 18-70 years old;
  • 5. patients with clear consciousness;
  • 6. Signing the informed consent form.

排除标准

  • 1. Patients with serious illnesses, such as heart, liver, kidney, endocrine diseases and hematopoietic system disease;
  • 2. Pregnant or lactating women;
  • 3. Patients who have mental confusion, who with a history of drug abuse or dependence, who allergic to study medication, who have participated in another clinical trial within 3 months, or who have other conditions not suitable for clinical study.

研究者

发起方
1. Xinhua affiliated hospital, Hubei University of Chinese Medicine; 2. Hubei Provincial Hospital of Integrated Chinese and Western Medicine

相似试验